BioMarin Pharmaceutical, Inc. (BMRN)
65.23
+0.56
(+0.87%)
USD |
NASDAQ |
Aug 31, 16:00
65.29
+0.06
(+0.09%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Long Term Debt (Quarterly) : 4.186B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.186B |
| March 31, 2026 | 1.440B |
| December 31, 2025 | 634.30M |
| September 30, 2025 | 604.24M |
| June 30, 2025 | 596.16M |
| March 31, 2025 | 601.96M |
| December 31, 2024 | 626.74M |
| September 30, 2024 | 602.69M |
| June 30, 2024 | 1.100B |
| March 31, 2024 | 1.097B |
| December 31, 2023 | 1.125B |
| September 30, 2023 | 1.086B |
| June 30, 2023 | 1.085B |
| March 31, 2023 | 1.084B |
| December 31, 2022 | 1.112B |
| September 30, 2022 | 1.082B |
| June 30, 2022 | 1.081B |
| March 31, 2022 | 1.080B |
| December 31, 2021 | 1.115B |
| September 30, 2021 | 1.078B |
| June 30, 2021 | 1.077B |
| March 31, 2021 | 1.076B |
| December 31, 2020 | 1.122B |
| September 30, 2020 | 1.497B |
| June 30, 2020 | 1.493B |
| Date | Value |
|---|---|
| March 31, 2020 | 906.34M |
| December 31, 2019 | 902.17M |
| September 30, 2019 | 901.61M |
| June 30, 2019 | 895.93M |
| March 31, 2019 | 885.58M |
| December 31, 2018 | 830.42M |
| September 30, 2018 | 1.200B |
| June 30, 2018 | 1.192B |
| March 31, 2018 | 1.183B |
| December 31, 2017 | 1.174B |
| September 30, 2017 | 1.166B |
| June 30, 2017 | 676.20M |
| March 31, 2017 | 690.93M |
| December 31, 2016 | 683.24M |
| September 30, 2016 | 675.64M |
| June 30, 2016 | 670.10M |
| March 31, 2016 | 668.01M |
| December 31, 2015 | 662.29M |
| September 30, 2015 | 667.79M |
| June 30, 2015 | 661.49M |
| March 31, 2015 | 655.49M |
| December 31, 2014 | 657.98M |
| September 30, 2014 | 656.88M |
| June 30, 2014 | 650.87M |
| March 31, 2014 | 661.42M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Incyte Corp. | 32.68M |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| BridgeBio Pharma, Inc. | 3.370B |
| Ionis Pharmaceuticals, Inc. | 2.189B |